ID   369F10
AC   CVCL_J907
SY   369F10.C3A8
DR   ATCC; HB-8682
DR   Wikidata; Q54585145
RX   Patent=US4753894;
RX   Patent=US4938948;
RX   Patent=US4956453;
RX   Patent=US5629197;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8682.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human high molecular weight mucin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
RX   Patent=US4753894;
RA   Frankel A.E., Ring D.B., Bjorn M.J.;
RT   "Monoclonal anti-human breast cancer antibodies.";
RL   Patent number US4753894, 28-Jun-1988.
//
RX   Patent=US4938948;
RA   Ring D.B., Frankel A.E.;
RT   "Method for imaging breast tumors using labeled monoclonal anti-human
RT   breast cancer antibodies.";
RL   Patent number US4938948, 03-Jul-1990.
//
RX   Patent=US4956453;
RA   Bjorn M.J., Frankel A.E., Laird W.J., Ring D.B., Winkelhake J.L.;
RT   "Anti-human ovarian cancer immunotoxins and methods of use thereof.";
RL   Patent number US4956453, 11-Sep-1990.
//
RX   Patent=US5629197;
RA   Ring D.B., Frankel A.E., Bjorn M.J.;
RT   "Monoclonal anti-human breast cancer antibodies.";
RL   Patent number US5629197, 13-May-1997.
//